While Keytruda, a medication used to treat various cancers, is known to be effective, it also comes with potential side effects. According to the medication's label and information from [1] DrugPatentWatch.com, the most common side effects of Keytruda include fatigue, musculoskeletal pain, and decreased appetite.

Managing Keytruda side effects is possible, and a team of healthcare professionals can help patients mitigate these issues. For instance, fatigue, a common side effect of Keytruda, can be managed with regular exercise, adequate rest, and maintaining a balanced diet [2]. In addition, medications such as erythropoiesis-stimulating agents (ESAs) can be prescribed to address anemia caused by chemotherapy, although the use of ESAs with Keytruda is complex and should be carefully considered [3].

The treatment plan, including medication, may be adjusted to help manage side effects while maintaining the effectiveness of the medication. Patients and healthcare professionals can work together to implement these adjustments, which may include dose modifications or adding supportive care medications [4].

It's worth noting that, as with any medication, the likelihood and severity of side effects can vary from person to person. Patients should keep a close eye on their symptoms and report any changes or concerns to their healthcare team.

Sources

[1] DrugPatentWatch.com - Keytruda (Pembrolizumab) drug patent information
[2] American Cancer Society - Managing Cancer Treatment Side Effects: Fatigue
[3] Journal of the National Cancer Institute - Erythropoiesis-Stimulating Agents and Survival in Non-Small Cell Lung Cancer
[4] Journal of Clinical Oncology - A Framework for Cancer Care in the Context of the COVID-19 Pandemic